Direkt zum Inhalt
Merck

475949

NMS-P715

≥98% (HPLC), powder, MPS1 inhibitor, Calbiochem®

Synonym(e):

MPS1-Inhibitor, NMS-P715, (N-(2,6-Diethylphenyl)-1-Methyl-8-({4-[(1-Methylpiperidin-4-yl)Carbamoyl]-2-(Trifluormethoxy)phenyl}amino)-4,5-Dihydro-1H-Pyrazol[4,3-h]Chinazolin-3-Carboxamid)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern

Über diesen Artikel

Empirische Formel (Hill-System):
C35H39F3N8O3
CAS-Nummer:
Molekulargewicht:
676.73
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Storage condition:
OK to freeze, protect from light
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Produktname

MPS1-Inhibitor, NMS-P715, The MPS1 Inhibitor, NMS-P715 controls the biological activity of MPS1. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

Quality Level

assay

≥98% (HPLC)

form

powder

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, protect from light

color

white

solubility

DMSO: 10 mg/mL, clear, colorless

shipped in

ambient

storage temp.

2-8°C

SMILES string

CN(N=C1C(NC2=C(CC)C=CC=C2CC)=O)C3=C1CCC4=C3N=C(NC5=CC=C(C(NC6CCN(C)CC6)=O)C=C5OC(F)(F)F)N=C4

InChI key

JFOAJUGFHDCBJJ-UHFFFAOYSA-N

General description

Ein oral bioverfügbarer, ATP-kompetitiver Pyrazolchinazolin-MPS1-Inhibitor (IC50 = 182 nM, Ki = 0,99 nM), der nachweislich reversibel und zeitabhängig wirkt. Er zeigt Selektivität für MPS1 gegenüber einer Gruppe von 60 Kinasen, wobei er nur gegen die drei Kinasen CK2, MELK und NEK6 wirkt (<10 M), but not against other mitotic kinases including PLK1, CDK1, Aurora A, Aurora B, or the SAC kinase BUB1, in an in vitro kinase assay. It promotes massive SAC (spindle assembly checkpoint) override (EC50 = 65 nM) in nocodazole-arrested U20S cells and elicits a reduction in the G1 and G2/M phase of the cell cycle in A2780 ovarian cancer cells, similar to RNAi-mediated MPS1 silencing. In addition, it is shown to inactivate SAC, delocalize kinetochore components, and inhibit the proliferation of select cancer cell lines (IC50 ~ 1 M), without marked activity among a panel of 127 normal cell lines. Also, it inhibits A2780 tumor xenograft growth in mice (90 mg/kg/day, o.s., in vivo) by 53% without marked body weight loss. Also available as a 5 mM solution in DMSO (Cat. No. 5.06313).

Packaging

Verpackt unter inertem Gas

Preparation Note

Nach der Rekonstitution in Aliquote aufteilen und einfrieren (-20 °;C). Stammlösungen sind bei -20 °;C bis zu 3 Monate haltbar.

Other Notes

Caldarelli, M., et al. 2011. Bioorg. Med. Chem. Lett.21, 4507.
Colombo, R., et al. 2011. Cancer Res.70, 10255.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxizität: Standard-Handhabung (A)


Lagerklasse

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Shangming Tang et al.
Nature, 606(7916), 930-936 (2022-04-28)
Chromothripsis is a catastrophic mutational process that promotes tumorigenesis and causes congenital disease1-4. Chromothripsis originates from aberrations of nuclei called micronuclei or chromosome bridges5-8. These structures are associated with fragile nuclear envelopes that spontaneously rupture9,10, leading to DNA damage when
Prasad Trivedi et al.
Nature, 618(7967), 1049-1056 (2023-06-15)
Chromothripsis, the shattering and imperfect reassembly of one (or a few) chromosome(s)1, is an ubiquitous2 mutational process generating localized and complex chromosomal rearrangements that drive genome evolution in cancer. Chromothripsis can be initiated by mis-segregation errors in mitosis3,4 or DNA
Akshay Narkar et al.
Cell reports, 34(12), 108892-108892 (2021-03-25)
Most solid tumors are aneuploid, and p53 has been implicated as the guardian of the euploid genome. Previous experiments using human cell lines showed that aneuploidy induction leads to p53 accumulation and p21-mediated G1 cell cycle arrest. We find that



Global Trade Item Number

SKUGTIN
475949-5MG04055977184273